<DOC>
	<DOCNO>NCT00517374</DOCNO>
	<brief_summary>To establish solid foundation , e.g . network coordinate centre test new SCI therapy forthcoming randomise control multi-centre clinical trial follow international standard guideline .</brief_summary>
	<brief_title>A Multi-Centre Clinical Study Spinal Cord Injury Patients Mainland China Hong Kong</brief_title>
	<detailed_description>This multicentre , observational , registry study outcome data SCI patient Mainland China Hong Kong . The target population consist patient SCI , acute SCI define &lt; 7 day post-injury chronic SCI define &gt; 12 month post-initial SCI surgery . A total 600 patient ( 300 acute 300 chronic ) enrol 6 city Mainland China ( namely : Beijing , Shanghai , Guangzhou , NingBo , Xi'an Kunming ) Hong Kong . The duration study one year , total 4 visit .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>General 1 . Male female adult subject , 18 65 year age 2 . Have clinical diagnosis SCI , define MRI 3 . Voluntarily sign date Informed Consent Form , approve Institutional Review Board ( IRB ) /Independent Ethics Committee ( IEC ) , prior studyspecific procedure Acute SCI Study Group : 4 . Has acute SCI ( define &lt; 7 day postinjury ) Chronic SCI Study Group : 4 . Has chronic SCI ( define &gt; 12 month postinitial SCI surgery ) General 1 . Severe head injury 2 . Is medically mentally unstable accord judgement Investigator 3 . History Multiple Sclerosis peripheral demyelinate disease 4 . Likely experimental therapy 5 . Any criterion , , opinion investigator , suggest subject would compliant study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>